Articles
6939 result(s) for 'sepsis' within Critical Care
Page 32 of 139
-
Citation: Critical Care 2019 23:151
-
Should we assume that hypothermia is a dysfunction in sepsis?
Citation: Critical Care 2017 21:8 -
Interleukin-26 is a promising biomarker of sepsis but is it always reliable?
Citation: Critical Care 2019 23:397 -
Adequate antibiotic therapy prior to ICU admission in patients with severe sepsis and septic shock reduces hospital mortality
In patients with severe sepsis and septic shock as cause of Intensive...
Citation: Critical Care 2015 19:302 -
Work of breathing, not dysoxia, as the cause of low central venous blood O2 saturation in sepsis
Citation: Critical Care 2016 20:291 -
Trends in sepsis mortality over time in randomised sepsis trials: a systematic literature review and meta-analysis of mortality in the control arm, 2002–2016
Epidemiologic data have shown an increasing incidence and declining mortality rate in sepsis. However, confounding effects due to differences...
Citation: Critical Care 2019 23:241 -
Determinants of sepsis knowledge: a representative survey of the elderly population in Germany
Sepsis is a life-threatening medical emergency requiring ... elderly. We therefore assessed sophisticated knowledge about sepsis in the German elderly population.
Citation: Critical Care 2018 22:273 -
Symmetrical (SDMA) and asymmetrical dimethylarginine (ADMA) in sepsis: high plasma levels as combined risk markers for sepsis survival
Nitric oxide (NO) regulates processes involved in sepsis progression, including vascular and immune function. ... concentrations of SDMA and ADMA are markers for sepsis survival.
Citation: Critical Care 2018 22:216 -
Impact of post-sepsis cardiovascular complications on mortality in sepsis survivors: a population-based study
It remains unclear whether sepsis-related cardiovascular complications have an adverse impact ... . To investigate the survival impact of post-sepsis cardiovascular complications among sepsis survivors, we conduc...
Citation: Critical Care 2019 23:293 -
The interleukin-27 -964A>G polymorphism enhances sepsis-induced inflammatory responses and confers susceptibility to the development of sepsis
Previous studies have identified critical roles of IL-27 in the pathological mechanisms of sepsis, and blockade of IL-27 may be a promising alternative therapy for sepsis. The purpose of this study was to...IL-27
Citation: Critical Care 2018 22:248 -
40th International Symposium on Intensive Care & Emergency Medicine
Citation: Critical Care 2020 24(Suppl 1):87 -
Interleukin-26 is overexpressed in human sepsis and contributes to inflammation, organ injury, and mortality in murine sepsis
Sepsis is a serious syndrome that is caused ... role in the orchestration of inflammatory response during sepsis. IL-26 is an emerging proinflammatory member ... However, its role in the pathogenesis of sepsis re...
Citation: Critical Care 2019 23:290 -
Discharge diagnoses versus medical record review in the identification of community-acquired sepsis
We evaluated the accuracy of hospital discharge diagnoses in the identification of community-acquired sepsis and severe sepsis.
Citation: Critical Care 2015 19:42 -
Prognostic value of NT-proBNP levels in the acute phase of sepsis on lower long-term physical function and muscle strength in sepsis survivors
Sepsis survivors often develop chronic critical illness (CCI ... proBNP blood levels in the acute phase of sepsis are associated with physical function and muscle ... strength impairment at 6 and 12 months after
Citation: Critical Care 2019 23:230 -
An ADAM10 promoter polymorphism is a functional variant in severe sepsis patients and confers susceptibility to the development of sepsis
Although genetic variants of the A disintegrin and metalloproteinase 10 (ADAM10) gene have been shown to be associated with susceptibility to several inflammatory-related diseases, to date little is known about t...
Citation: Critical Care 2015 19:73 -
Neutropenic sepsis is associated with distinct clinical and biological characteristics: a cohort study of severe sepsis
Immunocompromised patients who develop sepsis while neutropenic are at high risk for ... mortality; however, it is unknown if neutropenic sepsis is associated with distinct clinical and biological...
Citation: Critical Care 2016 20:222 -
Circulating adrenomedullin estimates survival and reversibility of organ failure in sepsis: the prospective observational multinational Adrenomedullin and Outcome in Sepsis and Septic Shock-1 (AdrenOSS-1) study
Adrenomedullin (ADM) regulates vascular tone and endothelial permeability during sepsis. Levels of circulating biologically active ADM ( ... present prospective observational multinational Adrenomedullin and Outc...
Citation: Critical Care 2018 22:354 -
Microvascular dysfunction as a cause of organ dysfunction in severe sepsis
Reduced microvascular perfusion has been implicated in organ dysfunction and multiple organ failure associated with severe sepsis. The precise mechanisms underlying microvascular dysfunction remain...
Citation: Critical Care 2005 9(Suppl 4):S9 -
Differentiated control of deranged nitric oxide metabolism: a therapeutic option in sepsis?
Derangement of nitric oxide (NO) metabolism represents one of the key mechanisms contributing to macro- and microcirculatory failure in sepsis. Sepsis-related therapy combining fluid resuscitation with administra...
Citation: Critical Care 2013 17:311 -
Early changes of CD4-positive lymphocytes and NK cells in patients with severe Gram-negative sepsis
Our aim was to define early changes of lymphocytes and of NK cells in severe sepsis and to correlate them with serum levels...
Citation: Critical Care 2006 10:R166 -
Clinical review: Drotrecogin alfa (activated) as adjunctive therapy for severe sepsis – practical aspects at the bedside and patient identification
Administration of drotrecogin alfa (activated) has been demonstrated to reduce mortality in patients with severe sepsis who are at high risk for death...
Citation: Critical Care 2003 7:445 -
Vitamin D deficiency as a risk factor for infection, sepsis and mortality in the critically ill: systematic review and meta-analysis
In Europe, vitamin D deficiency is highly prevalent varying between 40% and 60% in the healthy general adult population. The consequences of vitamin D deficiency for sepsis and outcome in critically ill patients ...
Citation: Critical Care 2014 18:660 -
Web-based application for predicting the potential target phenotype for recombinant human thrombomodulin therapy in patients with sepsis: analysis of three multicentre registries
A recent randomised controlled trial failed to demonstrate a beneficial effect of recombinant human thrombomodulin (rhTM) on sepsis. However, there is still controversy in the effects of rhTM for sepsis due to th...
Citation: Critical Care 2022 26:145 -
Combining intermediate levels of the Endotoxin Activity Assay (EAA) with other biomarkers in the assessment of patients with sepsis: results of an observational study
The Endotoxin Activity Assay (EAA) is a useful test to risk stratify patients with severe sepsis and assess for Gram negative infection. However...
Citation: Critical Care 2012 16:R88 -
Clinical review: Hypertonic saline resuscitation in sepsis
The present review discusses the hemodynamic effects of hypertonic saline in experimental shock and in patients with sepsis. We comment on the mechanisms of action ... . Specific actions of hypertonic saline in s...
Citation: Critical Care 2002 6:418 -
Microvascular resuscitation as a therapeutic goal in severe sepsis
Sepsis causes microvascular dysfunction. Increased heterogeneity of capillary ... mortality: it improves rapidly in survivors of sepsis but fails to improve in nonsurvivors. This ... a therapeutic goal. In animal...
Citation: Critical Care 2005 9(Suppl 4):S27 -
Validation of a method to partition the base deficit in meningococcal sepsis: a retrospective study
It is now possible to partition the base deficit at the bedside with enough accuracy to permit clinical use. This provides valuable information on the aetiology of acid–base disturbance when applied to a cohort o...
Citation: Critical Care 2005 9:R464 -
Differences in compliance with Surviving Sepsis Campaign recommendations according to hospital entrance time: day versus night
Higher compliance with Surviving Sepsis Campaign (SSC) recommendations has been associated...versus night) and its impact on hospital mortality.
Citation: Critical Care 2013 17:R79 -
Combination effect of antithrombin and recombinant human soluble thrombomodulin in a lipopolysaccharide induced rat sepsis model
The coadministration of AT and rhsTM might be effective for the treatment of severe sepsis.
Citation: Critical Care 2009 13:R203 -
Effects of dopexamine on the intestinal microvascular blood flow and leucocyte activation in a sepsis model in rats
Dopexamine may be a therapeutic option to improve hepatosplanchnic perfusion in sepsis. To investigate this possibility, we administered dopexamine in an experimental sepsis model in rats.
Citation: Critical Care 2006 10:R117 -
Microcirculatory alterations in ischemia–reperfusion injury and sepsis: effects of activated protein C and thrombin inhibition
Experimental studies in ischemia–reperfusion and sepsis indicate that activated protein C (APC)...In vivo..., however, the mechanisms of action have not been characterized thus far. Intravital multifluorescence m...
Citation: Critical Care 2005 9(Suppl 4):S33 -
A multicentre case-control study of nonsteroidal anti-inflammatory drugs as a risk factor for severe sepsis and septic shock
We aimed to establish whether the use of nonsteroidal anti-inflammatory drugs (NSAIDs) during evolving bacterial community-acquired infection in adults is associated with severe sepsis or septic shock.
Citation: Critical Care 2009 13:R43 -
Year in review 2008: Critical Care - sepsis
The present report highlights the most important papers appearing in Critical Care and other major journals about severe sepsis, the systemic inflammatory response and multiorgan dysfunction ... studies will have...
Citation: Critical Care 2009 13:224 -
Phenotype-specific therapeutic efficacy of ilofotase alfa in patients with sepsis-associated acute kidney injury
There is no effective treatment for sepsis-associated acute kidney injury (SA-AKI)....
Citation: Critical Care 2024 28:50 -
Bench-to-bedside review: Natural killer cells in sepsis - guilty or not guilty?
Bacterial sepsis and septic shock are complex inflammatory disorders ... the first time identified as important players during sepsis. The role of this cell type was...
Citation: Critical Care 2013 17:235 -
Filter survival time and requirement of blood products in patients with severe sepsis receiving drotrecogin alfa (activated) and requiring renal replacement therapy
Drotrecogin alfa (activated) (DrotAA) is licensed in the United States and the European Union for the treatment of severe sepsis with multiple organ failure. Patients with severe sepsis on renal replacement thera...
Citation: Critical Care 2008 12:R163 -
Near-infrared spectroscopy during stagnant ischemia estimates central venous oxygen saturation and mixed venous oxygen saturation discrepancy in patients with severe left heart failure and additional sepsis/septic shock
Discrepancies of 5-24% between superior vena cava oxygen saturation (ScvO2) and mixed venous oxygen saturation (SvO2) have been reported in patients with severe heart failure. Thenar muscle tissue oxygenation (St...
Citation: Critical Care 2010 14:R42 -
Bench-to-bedside review: Sepsis is a disease of the microcirculation
Microcirculatory perfusion is disturbed in sepsis. Recent research has shown that maintaining systemic ... associated with inadequate perfusion of the microcirculation in sepsis. Microcirculatory perfusion is reg...
Citation: Critical Care 2004 8:462 -
Low plasma citrulline levels are associated with acute respiratory distress syndrome in patients with severe sepsis
The role of nitric oxide synthase (NOS) in the pathophysiology of acute respiratory distress syndrome (ARDS) is not well understood. Inducible NOS is upregulated during physiologic stress; however, if NOS substra...
Citation: Critical Care 2013 17:R10 -
Recently published papers: Treating sepsis, measuring troponin and managing the obese
Sepsis and septic shock continue to contribute to ... the mitochondrial respiratory chain and the effects of sepsis coupled with interesting work on lactic acidosis. ... obese patient on a general ICU. Like sepsis
Citation: Critical Care 2005 9:535 -
Short women with severe sepsis-related acute lung injury receive lung protective ventilation less frequently: an observational cohort study
A total of 421 severe sepsis-related ALI subjects in the Consortium to...
Citation: Critical Care 2011 15:R262 -
Complement activation in severely ill patients with sepsis: no relationship with inflammation and disease severity
Sepsis is characterized by a dysregulated immune response ... and inflammation in relationship with adverse outcomes in sepsis patients is unclear.
Citation: Critical Care 2023 27:63 -
G-CSF and IL-8 for early diagnosis of sepsis in neonates and critically ill children – safety and cost effectiveness of a new laboratory prediction model: study protocol of a randomized controlled trial [ISRCTN91123847]
All patients admitted to the multidisciplinary neonatal and paediatric intensive care unit of a university children's hospital will be included. Patients will be allocated either to routine sepsis work up or to t...
Citation: Critical Care 2004 8:R443 -
Intravenous colistin in the treatment of sepsis from multiresistant Gram-negative bacilli in critically ill patients
The increasing prevalence of multiresistant Gram-negative strains in intensive care units (ICUs) has recently rekindled interest in colistin, a bactericidal antibiotic that was used in the 1960s for treatment of ...
Citation: Critical Care 2003 7:R78 -
Recombinant human activated protein C resets thrombin generation in patients with severe sepsis – a case control study
Recombinant human activated protein C (rhAPC) is the first drug for which a reduction of mortality in severe sepsis has been demonstrated. However, the mechanism ... fibrinolytic action of rhAPC in patients with ...
Citation: Critical Care 2005 9:R490 -
The 372 T/C genetic polymorphism of TIMP-1 is associated with serum levels of TIMP-1 and survival in patients with severe sepsis
Previous studies have found higher circulating levels of tissue inhibitor of matrix metalloproteinase (TIMP)-1 in nonsurviving septic patients than in surviving septic patients, and an association between the 372...
Citation: Critical Care 2013 17:R94 -
Reduction of D-dimer levels after therapeutic administration of antithrombin in acquired antithrombin deficiency of severe sepsis
In acute disseminated intravascular coagulation, the effect of antithrombin (AT) administration on elevated levels of D-dimer is not well established. In the present study, we report on changes in circulating lev...
Citation: Critical Care 2005 9:R596 -
Bench-to-bedside review: The promise of rapid infection diagnosis during sepsis using polymerase chain reaction-based pathogen detection
Early infection diagnosis as the cause of a patient's systemic inflammatory syndrome is an important facet of sepsis care bundles aimed at saving lives. Microbiological ... are essential during the immediate mana...
Citation: Critical Care 2009 13:217 -
Plasma adrenomedullin is associated with short-term mortality and vasopressor requirement in patients admitted with sepsis
The incidence of death among patients admitted for severe sepsis or septic shock is high. Adrenomedullin ( ... the hyperdynamic response during the early stages of sepsis. Pilot studies indicate an association of...
Citation: Critical Care 2014 18:R34 -
Downregulation of protein disulfide isomerase in sepsis and its role in tumor necrosis factor-alpha release
Protein disulfide isomerase (PDI) is an important factor for the protein modification step in the post-translational event. PDI plays an essential role in cell survival under various stress conditions. It has bee...
Citation: Critical Care 2008 12:R100
Follow
- ISSN: 1364-8535 (electronic)